Effect of polymer nanoparticles on atherosclerotic lesions and the associated mechanisms: a review.
- Author:
Hang ZOU
1
;
Yan LONG
2
;
Yuzhen REN
1
;
Tieying YIN
1
Author Information
- Publication Type:Journal Article
- Keywords: atherosclerosis; biosafety; nanoparticle; polymer
- MeSH: Humans; Polymers/chemistry*; Cardiovascular Diseases; Nanoparticles/chemistry*; Drug Delivery Systems; Atherosclerosis/pathology*
- From: Chinese Journal of Biotechnology 2023;39(4):1390-1402
- CountryChina
- Language:Chinese
- Abstract: Polymer nanoparticles generally refer to hydrophobic polymers-based nanoparticles, which have been extensively studied in the nanomedicine field due to their good biocompatibility, efficient long-circulation characteristics, and superior metabolic discharge patterns over other nanoparticles. Existing studies have proved that polymer nanoparticles possess unique advantages in the diagnosis and treatment of cardiovascular diseases, and have been transformed from basic researches to clinical applications, especially in the diagnosis and treatment of atherosclerosis (AS). However, the inflammatory reaction induced by polymer nanoparticles would induce the formation of foam cells and autophagy of macrophages. In addition, the variations in the mechanical microenvironment of cardiovascular diseases may cause the enrichment of polymer nanoparticles. These could possibly promote the occurrence and development of AS. Herein, this review summarized the recent application of polymer nanoparticles in the diagnosis and treatment of AS, as well as the relationship between polymer nanoparticles and AS and the associated mechanism, with the aim to facilitate the development of novel nanodrugs for the treatment of AS.
